Aikang

What Aikang does

Aikang (深圳市爱康生物科技股份有限公司) is a Shenzhen-based privately held Chinese in vitro diagnostics (IVD) company founded in May 2003, classified as a National High-tech Enterprise and National Key Little Giant Enterprise. The company develops, manufactures, and services automated medical equipment, reagents, and consumables across four core technology platforms: enzyme-linked immunosorbent assay (ELISA), blood typing (microcolumn gel / MGI method), chemiluminescence immunoassay (CLIA), and POCT. Its product portfolio spans automated blood type analyzers (Aigel, Metis, Poseidon series), single-test and high-throughput CLIA systems (CLIA-mate, C 900, C 1800, Lumimate 300A), the URANUS AE ELISA series, automated platelet antibody analyzers, and sample processing systems (Master, AiSort, AiStar). Aikang also operates a CDMO platform providing one-stop development and manufacturing services for third-party IVD products.

The company serves two primary customer segments across China: hospitals and clinical testing institutions requiring automated immunodiagnostic equipment, and blood stations and blood banks requiring blood typing, blood screening, and blood component preparation solutions. Aikang reports 8,000+ cooperative units across 30+ Chinese provinces, a 60,000+ sqm production and R&D base in Pingshan District Shenzhen, and a new Huiyang Intelligent Manufacturing Center under construction in Huizhou. International sales are pursued through direct marketing and trade shows including MEDICA, AACC, Medlab Middle East, CACLP, and CMEF. The company operates two wholly-owned subsidiaries — Aikang Diagnostics (reagents) and Aisikang MedTech (consumables) — and holds approximately 200 product registration certificates, including Class III medical devices, forming a regulatory moat. Pricing is not publicly disclosed; revenue is generated through direct sales of hardware, recurring reagent and consumable sales tied to the installed base, and CDMO services. No public revenue or funding figures are disclosed.

Name

Aikang

Legal name

深圳市爱康生物科技股份有限公司

Website

https://aikang-medical.com

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Short description

Aikang (深圳市爱康生物科技股份有限公司) is a Shenzhen-based IVD medical device company developing automated blood typing, chemiluminescence immunoassay, ELISA, and blood station laboratory automation systems, serving hospitals and blood banks across 30+ Chinese provinces and select international markets.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro industry

PRIMARYHLAHAAAM

IVD Reagents, Assay Kits & Consumables (Non-instrument)

Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics

SECONDARYHLAGABAK

Clinical Trial Material (CTM) Manufacturing & Supply CDMO

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)

Keywords

• In vitro diagnostics
• Automated immunoassay analyzers
• Blood bank equipment
• Medical device manufacturing
• CDMO services

Headquarters

HQ city

Shenzhen, Guangdong

HQ country

China

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Sale of automated medical equipment including chemiluminescence analyzers, blood group analyzers, ELISA instruments, and sample processing systems.
2. IVD Reagent Sales: Sale of in vitro diagnostic reagents covering infectious diseases, sex hormones, thyroid function, inflammation, tumor markers, cardiovascular, blood grouping and other fields.
3. Medical Consumables: Production and sale of medical plastic consumables including sampling tips, 96-well microplates, and plastic cards.
4. CDMO Services: Contract Development and Manufacturing Organization services providing one-stop solutions for medical device and IVD product development and manufacturing.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Aikang designs, manufactures, and sells in vitro diagnostic (IVD) medical equipment, reagents, and consumables for hospitals and blood stations. Its core product lines span chemiluminescence immunoassay analyzers, automated blood grouping analyzers, ELISA workstations, blood station laboratory automation lines, automated sample processing systems, blood bank storage and preparation equipment, IVD reagents, and medical plastic consumables. The company also provides CDMO (Contract Development and Manufacturing Organization) services for medical device and IVD product development and manufacturing.

Product overview

Aikang (深圳市爱康生物科技股份有限公司) is a national high-tech enterprise founded in 2003, specializing in IVD (in vitro diagnostics) equipment and reagents. The company offers a comprehensive platform of six major IVD technology series: chemiluminescence immunoassay (CLIA), enzyme-linked immunosorbent assay (ELISA), microcolumn gel (MGT), blood grouping, POCT, and immunofluorescence. The core portfolio includes automated analyzers (CLIA analyzers: CLIA-mate Plus, CLIA-mate 1200, C 900, C 1800, Lumimate 300A; blood type analyzers: Aigel series, Metis series; ELISA analyzers: URANUS AE series), sample processing systems (Master, AiSort, AiStar), blood bank equipment (Aidepot, Oceanus, Aisep), a full range of reagents (blood type cards, chemiluminescence reagents, ELISA reagents), and medical consumables (sampling tips, microplates, cards). The company also provides CDMO services. Products cover clinical diagnostics in blood analysis, infection, reproductive health, diabetes, cardiovascular, tumor monitoring, and endocrine metabolism. The company has approximately 200+ product registration certificates and operates through subsidiaries including Aikang Diagnostics and Aisikang MedTech.

Differentiator

Problem solved

Functional benefit

Brands

• URANUS AE Series: Automatic ELISA Analyzer series - China's first ELISA automatic instruments, suitable for blood institutions
• Aigel Series
• CLIA-mate Series
• C Series
• Lumimate 300A
• Metis Series
• AiSort
• AiStar 670
• AiNP 96
• CDMO Platform

Products and services

• Single-test Chemiluminescence Immunoassay (CLIA) Platform Single-test chemiluminescence immunoassay platform featuring the ALP-AMPPD reaction system and single-dose reagent strip integration, combining CLIA accuracy with POCT efficiency. Includes CLIA-mate Plus, CLIA-mate 1200, C 900, C 1800, and Lumimate 300A models for hospitals and clinical laboratories.
• Blood Type Detection System Automated blood grouping systems using microcolumn gel immunoassay technology (MGI), recommended by AABB. Includes Aigel 300, Aigel 400, Aigel 90, Aigel 50, Aigel Mini, and Metis 200 Plus analyzers with matching gel cards for hospitals and blood stations.
• URANUS AE Series Automated ELISA System Fully automatic ELISA analyzers for blood station and clinical laboratory use. Series includes URANUS AE 5, AE 8, AE 55, AE 65, AE 85, AE 95, AE 115, AE 145, AE 175, and AE 275 models with varying throughputs and robotic configurations.
• Laboratory Automation Line for Blood Station World's first laboratory automation line specifically designed for blood stations, enabling automated sample pre-processing, automated ELISA, clinical chemistry, blood grouping, and sample post-processing with flexible instrument configuration.
• Sample Processing System Automated sample processing systems including Master fully automatic sample processing system, AiSort automatic sample processing system (up to 1,200 samples/hour), and AiStar 670 sample transfer system for blood station laboratories and hospital testing laboratories.
• AiNP 96 Nucleic Acid Extraction System Automated nucleic acid extraction system using magnetic bead separation technology, processing up to 96 samples per run with pneumatic displacement sampling and capacitive liquid level detection.
• Xantus Fully Automated Pipetting System High-performance automated pipetting system introduced from Swiss Sias, featuring 88 specimens in 7 minutes, disposable pipetting tips for high cleanliness, and 192 sample capacity.
• Uranus Fully Automated Pipetting System Automated pipetting system with pressure sensing liquid level detection, full Chinese software interface, and flexible hardware configuration for various user needs.
• Blood Bank Equipment Blood bank equipment including Aidepot Intelligent Blood Refrigeration System for standardized and automated blood storage, Oceanus Plasma Freezer for standardized plasma quick freezing, and Aisep 100 Automatic Whole Blood Component Separator.
• IVD Reagents IVD reagents covering blood type detection, chemiluminescence, ELISA, and immunodiagnostics, including ABO/Rh blood grouping cards, irregular antibody screening reagents, sex hormones, thyroid function, cardiac markers, inflammation markers, tumor markers, and infectious disease testing.
• Medical Consumables Over 20 types of medical plastic consumables including sampling tips (black electric capacity, white air pressure, blue standard), 96-well microplates, plastic cards, deep well plates, and POCT cards and gel cards.
• CDMO Service Platform Contract Development and Manufacturing Organization (CDMO) platform providing one-stop services for medical device and IVD reagent development, manufacturing, and customization.
• Automated Platelet Antibody Analyzer Automated platelet antibody detection analyzer for clinical and blood station use, used to detect platelet antibodies in patient and donor samples.
• Irregular Antibody Screening Red Blood Cells Irregular antibody screening red blood cell reagent product for pre-transfusion testing in blood banks and clinical laboratories.
• ABO/RhD Blood Type Antigen Detection Reagent Kit (Solid Phase Method) Domestic-first ABO/RhD blood type antigen detection reagent kit using solid phase method enabling 1-minute blood type identification for blood banks and clinical laboratories.

Quantifiable outcome

• 8000+ cooperative units served
• +2 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• Jiangsu Provincial Blood Transfusion Association (江苏省输血协会)coreStrategic or Co-development Partner · 18 October 2022Jiangsu Provincial Blood Transfusion Association and Aikang signed a scientific research fund cooperation agreement. The partnership aims to create an industry-academia-research integrated development platform to promote innovation in Jiangsu blood transfusion medicine and enhance blood transfusion service levels.

Scale indicators5 records

Recent moves9 records

Expansion highlights6 records

Broad incumbents

• Roche Diagnostics: Global IVD market leader across immunoassay, clinical chemistry, and molecular diagnostics. Competes with Aikang in Chinese hospital markets, particularly in high-tier hospitals where Roche's cobas and Elecsys platforms dominate.
• Siemens Healthineers: Global IVD player with ADVIA Centaur and Atellica immunoassay systems, plus significant blood banking and lab automation offerings. Competes with Aikang in Chinese tier 1/2 hospital markets across immunoassay and lab automation.
• Bio-Rad Laboratories: Global diagnostics and life science company with significant blood typing, quality control, and clinical diagnostics product lines. Direct overlap with Aikang's blood banking instrument and reagent portfolio.
• Mindray Bio-Medical Electronics: China's largest medical device company with significant IVD operations spanning chemiluminescence, hematology, and clinical chemistry. Larger and broader portfolio than Aikang but competes directly across multiple Chinese IVD segments.
• Abbott Diagnostics: Global IVD leader with ARCHITECT immunoassay systems and significant presence in Chinese hospital and reference laboratory markets. Competes with Aikang's chemiluminescence platform at the high end of the Chinese market.

Direct peers

• Maccura Biotechnology: Sichuan-based Chinese IVD manufacturer with broad product portfolio across clinical chemistry, immunoassay, and blood banking reagents. Comparable to Aikang in targeting Chinese hospital laboratories with integrated instrument-reagent solutions.
• Autobio Diagnostics: Major Chinese IVD company offering chemiluminescence, ELISA, microbiology, and clinical chemistry systems. Direct competitor across multiple of Aikang's core technology platforms in the Chinese hospital and blood station market.
• Snibe (Shenzhen New Industries Biomedical Engineering): Shenzhen-headquartered Chinese IVD leader specializing in chemiluminescence immunoassay (CLIA) platforms and reagents. Direct competitor to Aikang in single-test CLIA and high-throughput CLIA analyzer categories serving hospital laboratories.
• Wanfu Bio (Wondfo): Chinese POCT and IVD company with strong position in rapid diagnostic testing and emerging chemiluminescence offerings. Comparable to Aikang's POCT platform and reagent business targeting Chinese clinical markets.
• Ortho Clinical Diagnostics: Global leader in blood banking and transfusion medicine diagnostics, with strong presence in immunohematology automated blood typing analyzers. Directly comparable to Aikang's blood group analyzer and microcolumn gel-based products serving blood banks worldwide.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/aikang-medtech

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aikang